Cargando…

Vitamin D and renal outcome: the fourth outcome of CKD-MBD? Oshima Award Address 2015

Bone fracture, cardiovascular events, and mortality are three outcomes of chronic kidney disease-mineral and bone disorder (CKD-MBD), and the umbrella concept originally described for dialysis patients. The reported association of serum phosphorus or fibroblast growth factor 23 (FGF23) levels with r...

Descripción completa

Detalles Bibliográficos
Autor principal:	Hamano, Takayuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2017
Materias:	Invited Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838134/ https://www.ncbi.nlm.nih.gov/pubmed/29270765 http://dx.doi.org/10.1007/s10157-017-1517-3

Ejemplares similares

Reverse translational research of autophagy and metabolism in kidney disease: Oshima Award Address 2018
por: Kimura, Tomonori
Publicado: (2019)

Generation of chimeric kidneys using progenitor cell replacement: Oshima Award Address 2021
por: Yamanaka, Shuichiro
Publicado: (2022)

The pathophysiological role of angiotensin receptor-binding protein in hypertension and kidney diseases: Oshima Award Address 2019
por: Wakui, Hiromichi
Publicado: (2020)

Novel tubular–glomerular interplay in diabetic kidney disease mediated by sirtuin 1, nicotinamide mononucleotide, and nicotinamide adenine dinucleotide Oshima Award Address 2017
por: Hasegawa, Kazuhiro
Publicado: (2019)

The Role of Vitamin K in CKD-MBD
por: Fusaro, Maria, et al.
Publicado: (2022)

Which Vitamin D in CKD-MBD? The Time of Burning Questions
por: Galassi, Andrea, et al.
Publicado: (2013)

Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β(2)-microglobulin-related amyloidosis and indoxyl sulfate-induced atherosclerosis—Oshima Award Address 2016
por: Yamamoto, Suguru
Publicado: (2018)

Prevention and Treatment of CKD-MBD
por: Cozzolino, Mario
Publicado: (2013)

CKD-MBD after kidney transplantation
por: Wesseling-Perry, Katherine, et al.
Publicado: (2011)

A Japanese approach for CKD-MBD
por: Yokoyama, Keitaro, et al.
Publicado: (2013)

CKD-MBD diagnosis: biochemical abnormalities
por: Lucca, Leandro Junior, et al.
Publicado: (2021)

Clinical significance of parathyroid intervention on CKD-MBD management
por: Ogata, Hiroaki, et al.
Publicado: (2008)

Emerging cross-talks between chronic kidney disease–mineral and bone disorder (CKD–MBD) and malnutrition–inflammation complex syndrome (MICS) in patients receiving dialysis
por: Yamada, Shunsuke, et al.
Publicado: (2022)

Effect of cholecalciferol on serum hepcidin and parameters of anaemia and CKD-MBD among haemodialysis patients: a randomized clinical trial
por: Obi, Yoshitsugu, et al.
Publicado: (2020)

Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysis
por: Block, Geoffrey A., et al.
Publicado: (2016)

Gaps between Global Guidelines and Local Practices in CKD-MBD
por: Kim, Gheun-Ho
Publicado: (2014)

CKD-MBD KDIGO guidelines: how difficult is reaching the ‘target’?
por: Cozzolino, Mario
Publicado: (2018)

CKD-MBD in Brazil: the gap between reality and the recommended guidelines
por: Custódio, Melani Ribeiro
Publicado: (2018)

Diagnosis of bone abnormalities in CKD-MBD (Imaging and bone biopsy)
por: Bucharles, Sérgio Gardano Elias, et al.
Publicado: (2021)

Role of Chronic Kidney Disease (CKD)–Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD
por: Yamada, Shunsuke, et al.
Publicado: (2023)

Association between CKD-MBD and mortality in older patients with advanced CKD—results from the EQUAL study
por: Magagnoli, Lorenza, et al.
Publicado: (2023)

Should We Consider the Cardiovascular System While Evaluating CKD-MBD?
por: Rroji, Merita, et al.
Publicado: (2020)

Testing Patterns for CKD-MBD Abnormalities in a Sample US Population
por: Wetmore, James B., et al.
Publicado: (2021)

Can we reverse arterial stiffness by intervening on CKD-MBD biomarkers?
por: Vervloet, Marc G
Publicado: (2023)

Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD
por: Behets, Geert J., et al.
Publicado: (2017)

Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD): Current Perspectives
por: Waziri, Bala, et al.
Publicado: (2019)

Magnesium—A More Important Role in CKD–MBD than We Thought
por: Peride, Ileana, et al.
Publicado: (2022)

Effects of diuretics furosemide and hydrochlorothiazide on CKD-MBD: A prospective randomized study
por: Vasco, Raquel F.V., et al.
Publicado: (2021)

Renal association commentary on the KDIGO (2017) clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of CKD-MBD
por: Burton, James O., et al.
Publicado: (2018)

2017 Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update Implementation: Asia Summit Conference Report
por: Wang, Angela Yee-Moon, et al.
Publicado: (2019)

Introduction: expanding concepts of chronic kidney disease-mineral and bone disorder (CKD-MBD)
por: Fukagawa, Masafumi, et al.
Publicado: (2013)

The Influence of Dietary Interventions on Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)
por: Rysz, Jacek, et al.
Publicado: (2021)

Diagnosis and management of mineral and bone disorders in infants with CKD: clinical practice points from the ESPN CKD-MBD and Dialysis working groups and the Pediatric Renal Nutrition Taskforce
por: Bacchetta, Justine, et al.
Publicado: (2023)

Clinical Significance of Adropin and Afamin in Evaluating Renal Function and Cardiovascular Health in the Presence of CKD-MBD Biomarkers in Chronic Kidney Disease
por: Kaur, Rupinder, et al.
Publicado: (2023)

Pandemic Influenza Virus Surveillance, Izu-Oshima Island, Japan
por: Inamasu, Tomoko, et al.
Publicado: (2012)

Impact of cinacalcet introduction on MBD management: the MBD-5D study in Japan
por: Fukuma, Shingo, et al.
Publicado: (2013)

Biopsy-proven CKD etiology and outcomes: the Chronic Kidney Disease Japan Cohort (CKD-JAC) study
por: Hamano, Takayuki, et al.
Publicado: (2022)

Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2017;7:1–59
Publicado: (2017)

The emerging role of magnesium in CKD
por: Sakaguchi, Yusuke
Publicado: (2022)

Vitamin D in prostate cancer
por: Trump, Donald L, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_n08r6n6rrps0hrn35n5sh1bh0l